Abbott Laboratories Statistics

Total Valuation

Abbott Laboratories has a market cap or net worth of EUR 190.20 billion. The enterprise value is 197.39 billion.

Market Cap	190.20B
Enterprise Value	197.39B

Important Dates

The next estimated earnings date is Wednesday, January 22, 2025.

Earnings Date	Jan 22, 2025
Ex-Dividend Date	Oct 15, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.12%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.72B

Valuation Ratios

The trailing PE ratio is 36.93.

PE Ratio	36.93
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	24.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.39, with an EV/FCF ratio of 33.94.

EV / Earnings	38.33
EV / Sales	4.99
EV / EBITDA	18.39
EV / EBIT	27.05
EV / FCF	33.94

Financial Position

The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.38.

Current Ratio	1.60
Quick Ratio	1.00
Debt / Equity	0.38
Debt / EBITDA	1.35
Debt / FCF	2.32
Interest Coverage	13.06

Financial Efficiency

Return on equity (ROE) is 14.84% and return on invested capital (ROIC) is 8.76%.

Return on Equity (ROE)	14.84%
Return on Assets (ROA)	6.49%
Return on Capital (ROIC)	8.76%
Revenue Per Employee	324,168
Profits Per Employee	45,176
Employee Count	114,000
Asset Turnover	0.56
Inventory Turnover	2.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.24% in the last 52 weeks. The beta is 0.72, so Abbott Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+9.24%
50-Day Moving Average	109.09
200-Day Moving Average	102.05
Relative Strength Index (RSI)	51.55
Average Volume (20 Days)	409

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.64

Income Statement

In the last 12 months, Abbott Laboratories had revenue of EUR 36.96 billion and earned 5.15 billion in profits. Earnings per share was 2.95.

Revenue	36.96B
Gross Profit	20.66B
Operating Income	6.82B
Pretax Income	6.08B
Net Income	5.15B
EBITDA	9.71B
EBIT	6.82B
Earnings Per Share (EPS)	2.95

Full Income Statement

Balance Sheet

The company has 6.98 billion in cash and 13.49 billion in debt, giving a net cash position of -6.51 billion.

Cash & Cash Equivalents	6.98B
Total Debt	13.49B
Net Cash	-6.51B
Net Cash Per Share	n/a
Equity (Book Value)	35.89B
Book Value Per Share	20.57
Working Capital	7.98B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.83 billion and capital expenditures -2.01 billion, giving a free cash flow of 5.82 billion.

Operating Cash Flow	7.83B
Capital Expenditures	-2.01B
Free Cash Flow	5.82B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.91%, with operating and profit margins of 18.44% and 13.99%.

Gross Margin	55.91%
Operating Margin	18.44%
Pretax Margin	16.44%
Profit Margin	13.99%
EBITDA Margin	26.26%
EBIT Margin	18.44%
FCF Margin	15.74%

Dividends & Yields

This stock pays an annual dividend of 2.02, which amounts to a dividend yield of 1.87%.

Dividend Per Share	2.02
Dividend Yield	1.87%
Dividend Growth (YoY)	7.76%
Years of Dividend Growth	5
Payout Ratio	65.30%
Buyback Yield	0.12%
Shareholder Yield	1.99%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Abbott Laboratories has an Altman Z-Score of 5.04.

Altman Z-Score	5.04
Piotroski F-Score	n/a